SPECSURE OPTICIANS (CONSETT) LIMITEDActive
Key figures
SPECSURE OPTICIANS (CONSETT) LIMITED does not disclose its turnover in its latest accounts; the profit for the year is as stated in the accounts.
Ratios
2025Balance sheet structure
Filed accounts2020–2025
| 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|
| Profit for the year | — | — | 779,167 | 819,189 | 972,010 |
| Cash at bank and in hand | 35,989 | 198,048 | 18,501 | 59,799 | 57,750 |
| Total assets | 2,061,197 | 2,576,152 | 3,301,105 | 4,083,254 | 5,149,616 |
| Total liabilities | — | 370,472 | 320,869 | 263,997 | 372,425 |
| Net assets / total equity | 1,556,076 | 2,187,773 | 2,966,939 | 3,786,128 | 4,764,524 |
| Average number of employees | 22 | 26 | 24 | 29 | 26 |
| Average pay (per year) | — | — | 23,878 | 20,977 | 23,116 |
A dash (—) means no accounts were filed for that year or the item is not in the accounts; 0 is a zero stated in the accounts. Small companies usually file only a balance sheet, so the profit and loss account is often missing.
Summary: SPECSURE OPTICIANS (CONSETT) LIMITED
Company
SPECSURE OPTICIANS (CONSETT) LIMITED is a private limited company registered with Companies House under company number 05807940. It was incorporated on 5 May 2006. Its status is active. The registered office is in Consett (DH8). Its nature of business (SIC 2007) is other human health activities (86900).
Accounts
The latest accounts in the database are for 2025 (period ending 31 Dec 2025); the company files abridged accounts (unaudited). Profit for the year was £972,010. Net assets were £4,764,524, up 25.8% on the previous year. Cash at bank and in hand was £57,750. Total assets were £5,149,616 and total liabilities £372,425. The company had an average of 26 employees. Figures are available for 6 financial years (2020–2025).
Control and charges
One person with significant control is registered. 2 of 2 registered charges are outstanding.
Filing deadlines
The next accounts are due by 30 Sep 2027. The next confirmation statement is due by 19 May 2027.